Suchergebnisse - "Dispenzieri, Angela"

PubPharm (41)

1

Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation

enthalten in: Blood cancer journal | 2022

von Al Saleh, A. | Ebraheem, M. | Sidiqi, M. | +13

2

A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis

enthalten in: Leukemia | 2022

von Dispenzieri, A. | Kastritis, E. | Wechalekar, A. | +12

3

Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide

enthalten in: European journal of haematology | 2021

von Hwa, Y. | Lacy, M. | Gertz, M. | +16

4

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM : FIRST trial subanalysis of Canadian/US patients

enthalten in: Cancer medicine | 2020

von Belch, A. | Bahlis, N. | White, D. | +11

5

POEMS Syndrome : 2019 Update on diagnosis, risk-stratification, and management

enthalten in: American journal of hematology | 2019

von Dispenzieri, A.

6

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

enthalten in: American journal of hematology | 2018

von Lakshman, A. | Singh, P. | Rajkumar, S. | +21

7

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

enthalten in: Blood | 2017

von Paludo, J. | Mikhael, J. | LaPlant, B. | +25

8

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2017

von Durie, B. | Hoering, A. | Abidi, M. | +10

CommentIn: Lancet. 2017 Feb 4;389(10068):480-482. - PMID 28017404

9

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

enthalten in: American journal of hematology | 2015

von Majithia, N. | Vincent Rajkumar, S. | Lacy, M. | +12

10

Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents

enthalten in: Leukemia & lymphoma | 2015

von Gertz, M. | Terpos, E. | Dispenzieri, A. | +6

1
2
3
4
5
Nächster »
[5]